Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CRL | MEDP | NTRA | ||
Company | Charles River Laboratories Intl | Medpace Holdings Inc | Natera Inc | ||
Price Information | |||||
Exchange | NYSE | NASDAQ | NASDAQ | ||
Open | 227.39 | 391.72 | 92.00 | ||
High | 230.86 | 397.17 | 92.83 | ||
Low | 227.39 | 388.88 | 91.05 | ||
Last | 229.03 | 395.93 | 91.66 | ||
Change | +1.22 | +6.16 | +0.38 | ||
% Change | +0.54% | +1.58% | +0.42% | ||
Volume | 322,100 | 144,600 | 568,900 | ||
20-Day Average Volume | 502,320 | 248,165 | 1,195,525 | ||
Previous Close | 227.81 | 389.77 | 91.28 | ||
Industry | Medical Services | Medical Services | Medical Services | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 243.13 | 392.63 | 92.25 | ||
20-Day Raw Stochastic | 11.12% | 61.55% | 54.37% | ||
20-Day Relative Strength | 39.43% | 53.13% | 55.69% | ||
Weighted Alpha | +17.93 | +97.84 | +87.43 | ||
Today's Opinion | 24% Buy | 56% Buy | 72% Buy | ||
Previous Opinion | 24% Buy | 40% Buy | 72% Buy | ||
Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +0.99% since 04/19/24 | +6.43% since 04/19/24 | +7.48% since 04/19/24 | ||
Low | 225.79 on 04/22/24 | 355.79 on 04/23/24 | 85.10 on 04/22/24 | ||
High | 244.56 on 04/24/24 | 421.00 on 04/24/24 | 93.64 on 04/24/24 | ||
1-Month | |||||
%Chg | -13.72% since 03/26/24 | -1.69% since 03/26/24 | +1.84% since 03/26/24 | ||
Low | 223.49 on 04/18/24 | 355.79 on 04/23/24 | 83.13 on 04/19/24 | ||
High | 273.32 on 04/01/24 | 421.00 on 04/24/24 | 98.82 on 04/05/24 | ||
3-Month | |||||
%Chg | +3.97% since 01/26/24 | +32.79% since 01/26/24 | +40.07% since 01/26/24 | ||
Low | 212.52 on 02/01/24 | 286.76 on 02/01/24 | 62.96 on 01/29/24 | ||
High | 275.00 on 03/08/24 | 421.00 on 04/24/24 | 98.82 on 04/05/24 | ||
6-Month | |||||
%Chg | +30.82% since 10/26/23 | +54.73% since 10/26/23 | +134.72% since 10/26/23 | ||
Low | 161.65 on 11/01/23 | 239.00 on 11/01/23 | 36.90 on 10/30/23 | ||
High | 275.00 on 03/08/24 | 421.00 on 04/24/24 | 98.82 on 04/05/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 11,797,565 | 12,267,095 | 11,204,701 | ||
Shares Outstanding, K | 51,511 | 30,983 | 122,242 | ||
Annual Sales | 4,129,410,000 | 1,885,840,000 | 1,082,570,000 | ||
Annual Net Income | 474,620,000 | 282,810,000 | -434,800,000 | ||
Last Quarter Sales | 1,013,480,000 | 498,400,000 | 311,110,000 | ||
Last Quarter Net Income | 187,080,000 | 78,300,000 | -78,030,000 | ||
60-Month Beta | 1.40 | 1.38 | 1.37 | ||
Per-Share Information | |||||
Most Recent Earnings | 2.46 on 02/14/24 | 3.20 on 04/22/24 | -0.64 on 02/28/24 | ||
Latest Earnings Date | 05/09/24 | 04/22/24 | 05/14/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 21.39 | 39.73 | 0.00 |